Annexon Inc

+0.23 (+7.57%)
Other Pre-Announcement

Annexon Posts Quarterly Loss Per Share $0.92

Published: 05/09/2022 21:23 GMT
Annexon Inc (ANNX) - Annexon Biosciences Highlights Portfolio Progress and Key Anticipated Milestones, and Reports First Quarter 2022 Financial Results.
Cash and Cash Equivalents and Short-term Investments Were $206.7 Million As of March 31, 2022.
Continues to Expect That Its Current Cash Position is Sufficient to Fund Its Operating Plans Into 2024.
Qtrly Loss per Share $0.92.
Q1 Earnings per Share View $-1.00 -- Refinitiv Ibes Data (analyst estimates).